Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
EARLY_PHASE1
100
about 5.1 years
18–100
1 site in MD
Why this study is shown
What this study is about
This trial is testing how long red blood cells survive in people with sickle cell disease (SCD) and other hemoglobinopathies. The researchers will use biotin labeling to track the lifespan of these cells, comparing them to those who have had a bone marrow transplant. This information could help improve treatments for these conditions.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Biotin-labeled red blood cells
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
ALIMENTARY TRACT AND METABOLISM
oral (Oral Tablet)